Daegu, South Korea

Yoeng Eun Yu

USPTO Granted Patents = 1 

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Yoeng Eun Yu in Treating Inflammatory Diseases.

Introduction

Yoeng Eun Yu is a notable inventor based in Daegu, South Korea. She has made significant contributions to the field of medicine, particularly in the treatment of inflammatory diseases. Her innovative approach focuses on developing compositions that are both effective and safe for use.

Latest Patents

Yoeng Eun Yu holds a patent for "Methods for treating inflammatory diseases." This invention provides a composition containing active ingredients, including Mel, which serves as an antitussive, expectorant, or anti-inflammatory agent. The composition is designed to prevent, alleviate, or treat respiratory diseases. It boasts excellent effects compared to existing antitussive and expectorant agents. The compositions are derived from natural materials and exhibit minimal cytotoxicity, making them suitable for use as medicine or food compositions with antitussive, expectorant, and anti-inflammatory properties. She has 1 patent to her name.

Career Highlights

Yoeng Eun Yu is currently associated with Okchundang Co., Ltd., where she continues to innovate in her field. Her work is characterized by a commitment to developing safe and effective treatments for various health conditions.

Collaborations

Throughout her career, she has collaborated with talented individuals such as Seong Min Ku and Tae Hun Ku. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Yoeng Eun Yu's contributions to the field of medicine through her innovative patent demonstrate her dedication to improving health outcomes. Her work in developing safe and effective treatments for inflammatory diseases is commendable and highlights the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…